应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02158 医渡科技
休市中 05-22 16:08:22
5.570
+0.270
+5.09%
最高
5.570
最低
5.280
成交量
416.11万
今开
5.280
昨收
5.300
日振幅
5.47%
总市值
56.81亿
流通市值
56.81亿
总股本
10.20亿
成交额
2,268万
换手率
0.41%
流通股本
10.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
异动解读 | 北京市委书记调研勉励,医渡科技盘中大涨5.09%
异动解读 · 05-22 16:00
异动解读 | 北京市委书记调研勉励,医渡科技盘中大涨5.09%
医渡科技(02158)再中标739万元AI医疗订单 近期密集揽获多项顶级医疗机构项目
智通财经 · 05-21 13:10
医渡科技(02158)再中标739万元AI医疗订单 近期密集揽获多项顶级医疗机构项目
医渡科技(02158):联属公司中标天津市肿瘤医院智能临床研究一体化平台建设项目
智通财经 · 05-21 12:33
医渡科技(02158):联属公司中标天津市肿瘤医院智能临床研究一体化平台建设项目
定义“医院AI操作系统”:北协和、南湘雅等顶级医院 为何集体选择医渡科技(02158)?
智通财经 · 05-19
定义“医院AI操作系统”:北协和、南湘雅等顶级医院 为何集体选择医渡科技(02158)?
从北京三甲到新加坡公立医院,医渡科技(02158)盈利背后的野心:成为医院的AI操作系统
智通财经 · 05-18
从北京三甲到新加坡公立医院,医渡科技(02158)盈利背后的野心:成为医院的AI操作系统
医渡科技(02158):联属公司中标重庆大学附属涪陵医院全院数据中心及信息化项目
智通财经 · 05-18
医渡科技(02158):联属公司中标重庆大学附属涪陵医院全院数据中心及信息化项目
格隆汇个股放量排行榜 | 5月13日
格隆汇 · 05-13
格隆汇个股放量排行榜 | 5月13日
医渡科技(02158)携手中肿十年共建:揭开医院真正需要的医疗AI真相
智通财经 · 05-13
医渡科技(02158)携手中肿十年共建:揭开医院真正需要的医疗AI真相
医渡科技(02158)再获中肿908万元AI订单 顶级医院深度复购印证营收爆发力
智通财经 · 05-11
医渡科技(02158)再获中肿908万元AI订单 顶级医院深度复购印证营收爆发力
医渡科技(02158)多点利好共振:机构调研认可、深圳惠民保主运营、项目中标频传
智通财经 · 05-11
医渡科技(02158)多点利好共振:机构调研认可、深圳惠民保主运营、项目中标频传
医渡科技(02158)中标中国银行股份有限公司广东省分行中山大学附属肿瘤医院智慧临床及结算服务升级建设项目
智通财经 · 05-11
医渡科技(02158)中标中国银行股份有限公司广东省分行中山大学附属肿瘤医院智慧临床及结算服务升级建设项目
以AI破解惠民保“死亡螺旋” 医渡科技(02158)开启价值兑现新周期
智通财经 · 05-08
以AI破解惠民保“死亡螺旋” 医渡科技(02158)开启价值兑现新周期
医渡科技更新2026年4月股份变动月报表,股本维持稳定
公告速递 · 05-07
医渡科技更新2026年4月股份变动月报表,股本维持稳定
2026年度“深圳惠民保”正式上线 医渡科技(02158)连续四年担任主运营
智通财经 · 05-07
2026年度“深圳惠民保”正式上线 医渡科技(02158)连续四年担任主运营
医渡科技(02158)附属成功中标Dr Buddy的落地实施及为其提供支持及维护
智通财经 · 05-06
医渡科技(02158)附属成功中标Dr Buddy的落地实施及为其提供支持及维护
告别溯源泥潭:医渡科技(02158)如何重构临床试验的“数据基因”?
智通财经 · 04-30
告别溯源泥潭:医渡科技(02158)如何重构临床试验的“数据基因”?
医渡科技(02158)用一场路演引爆CHIMA,医疗AI下半场怎么打?
智通财经 · 04-29
医渡科技(02158)用一场路演引爆CHIMA,医疗AI下半场怎么打?
医渡科技(02158)中标广医科大附一院临床试验SMO项目
智通财经网 · 04-28
医渡科技(02158)中标广医科大附一院临床试验SMO项目
医渡科技(02158)旗下医渡智循接入DeepSeek-V4,双模型协同临床辅助体验再升级
智通财经 · 04-24
医渡科技(02158)旗下医渡智循接入DeepSeek-V4,双模型协同临床辅助体验再升级
医渡科技(02158)3-4倍PE背后的AI医疗价值重估新叙事
智通财经 · 04-24
医渡科技(02158)3-4倍PE背后的AI医疗价值重估新叙事
加载更多
公司概况
公司名称:
医渡科技
所属市场:
SEHK
上市日期:
--
主营业务:
医渡科技有限公司是一家主要从事提供基于大数据和人工智能(AI)技术的医疗解决方案的投资控股公司。该公司主要通过三个分部运营其业务。大数据平台和解决方案分部从事提供数据智能平台及数据分析驱动的解决方案。生命科学解决方案分部从事为药物和医疗器械的全生命周期管理提供支持,涵盖从临床开发到上市后的各个阶段。健康管理平台和解决方案分部从事提供AI赋能的健康管理解决方案。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02158","market":"HK","secType":"STK","nameCN":"医渡科技","latestPrice":5.57,"timestamp":1779437302003,"preClose":5.3,"halted":0,"volume":4161100,"delay":0,"changeRate":0.05094339622641518,"floatShares":1019999999,"shares":1019999999,"eps":-0.111496,"marketStatus":"休市中","change":0.27,"latestTime":"05-22 16:08:22","open":5.28,"high":5.57,"low":5.28,"amount":22675344,"amplitude":0.054717,"askPrice":5.57,"askSize":23500,"bidPrice":5.55,"bidSize":9600,"shortable":3,"etf":0,"ttmEps":-0.091894,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779759000000},"marketStatusCode":7,"adr":0,"listingDate":1610640000000,"exchange":"SEHK","adjPreClose":5.3,"openAndCloseTimeList":[[1779413400000,1779422400000],[1779426000000,1779436800000]],"volumeRatio":0.8183409377224148,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02158","defaultTab":"news","newsList":[{"id":"1136532001","title":"异动解读 | 北京市委书记调研勉励,医渡科技盘中大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136532001","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136532001?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:00","pubTimestamp":1779436841,"startTime":"0","endTime":"0","summary":"医渡科技今日盘中股价大幅拉升,涨幅达到5.09%,市场关注度显著提升。消息面上,北京市委书记尹力于近期围绕“数智赋能健康北京建设”主题,对医渡科技进行了实地调研。尹力书记在调研中强调,要强化数据赋能科技创新,深挖数据价值推动产业高质量发展,并完善数据合规管理体系。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637809768","title":"医渡科技(02158)再中标739万元AI医疗订单 近期密集揽获多项顶级医疗机构项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2637809768","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637809768?lang=zh_cn&edition=full","pubTime":"2026-05-21 13:10","pubTimestamp":1779340214,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,医渡科技的AI医疗项目中标节奏明显加快。继拿下中山大学肿瘤防治中心、新加坡SingHealth等重磅项目后,这家AI医疗头部公司再度斩获来自顶级肿瘤专科医院的核心订单。5月21日午间,医渡科技发布自愿性公告,其联属公司医渡云(北京)技术有限公司中标天津市肿瘤医院智能临床研究一体化平台建设项目,项目总金额约739万元人民币。这是医渡科技4月以来公布的第八个中标公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","CHAT","BK1617","AIPO","ARTY","159891","02158","BK1189","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637806728","title":"医渡科技(02158):联属公司中标天津市肿瘤医院智能临床研究一体化平台建设项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2637806728","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637806728?lang=zh_cn&edition=full","pubTime":"2026-05-21 12:33","pubTimestamp":1779338035,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医渡科技 发布公告,近期,本公司的联属公司医渡云(北京)技术有限公司中标天津市肿瘤医院智能临床研究一体化平台建设项目,项目总金额约为人民币739万元。医渡科技是驱动中国医疗体系智能化升级的核心力量,公司以智慧决策深度赋能“医、药、险、患”全产业链,致力于使精准医疗惠及每一个人。医渡科技,以自主创新的系统级智能,创造更具韧性、更富关怀、更普惠高效的医疗健康未来。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1617","02158","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636833811","title":"定义“医院AI操作系统”:北协和、南湘雅等顶级医院 为何集体选择医渡科技(02158)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2636833811","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636833811?lang=zh_cn&edition=full","pubTime":"2026-05-19 15:11","pubTimestamp":1779174661,"startTime":"0","endTime":"0","summary":"在这份被视为行业“风向标”的报告中,医渡科技作为典型案例被多次提及。“北协和、南湘雅”们的信任票:从进院到复购在医疗AI行业,“进院”往往被视为成功的标志。据报告披露,医渡科技的循证引擎已获得北京协和医院的权威认可。至此,医渡科技完成了以北京协和医院为北方旗舰、以中南大学湘雅医院为南方重镇、以中肿和北肿等顶级专科医院为纵深阵地的精准覆盖。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ARTY","BK1617","02158","AGIX","BK1518","CHAT","BK1189","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636604296","title":"从北京三甲到新加坡公立医院,医渡科技(02158)盈利背后的野心:成为医院的AI操作系统","url":"https://stock-news.laohu8.com/highlight/detail?id=2636604296","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636604296?lang=zh_cn&edition=full","pubTime":"2026-05-18 14:19","pubTimestamp":1779085172,"startTime":"0","endTime":"0","summary":"5月6日,医渡科技宣布,其附属公司成功中标新加坡最大公立医疗集团SingHealth的Dr Buddy项目,合同金额约1220万元人民币。订单的加速、顶级医院的“深度复购”评判一家B2B医疗科技公司的成色,最严苛的标准莫过于顶级医院的复购率。医渡科技近期中标项目中,最富深意的并非金额本身,而是合作关系的深度与延续性。事实上,在准入门槛极高的顶尖三甲医院,让顶级医院及专家持续“复购”的难度,远高于首次准入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","AGIX","BK1617","BK1518","02158","AIPO","ARTY","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636012111","title":"医渡科技(02158):联属公司中标重庆大学附属涪陵医院全院数据中心及信息化项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2636012111","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636012111?lang=zh_cn&edition=full","pubTime":"2026-05-18 08:03","pubTimestamp":1779062623,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医渡科技 发布公告,近期,本公司的联属公司医渡云(北京)技术有限公司中标重庆数字涪陵大数据产业发展有限公司的重庆大学附属涪陵医院全院数据中心及信息化项目,项目总金额约为人民币964.95万元。医渡科技是驱动中国医疗体系智能化升级的核心力量,公司以智慧决策深度赋能“医、药、险、患”全产业链,致力于使精准医疗惠及每一个人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["DTCR","BK1617","BK1518","BK1189","BLOK","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635943788","title":"格隆汇个股放量排行榜 | 5月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635943788","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635943788?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:30","pubTimestamp":1778664605,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示,上一交易日腾讯音乐-SW(01698)、阳光保险(06963)、上海电气(02727)、轻松健康(02661)、弘毅文化集团(00419)、FIT HON TENG(06088)、京城机电股份(00187)、北方矿业(00433)、心玮医疗-B(06609)、同源康医药-B(02410)、富通科技(00465)、京东物流(02618)、云顶新耀(01952)、赛晶科技(005","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/13173057083788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02171","81024","00719","09688","01548","01951","06186","02276","01905","01952","06049","06060","00013","00772","02126","06660","06609","09626","09888","03700","01833","09699","01357","02192","00762","01024","06969","02306","06160","06996","00169","01440","02618","02096","01783","02256","06963","09992","01060","02285","02013","00136","00909","02158","02197","02252","03692","02172","09858","03888"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635422459","title":"医渡科技(02158)携手中肿十年共建:揭开医院真正需要的医疗AI真相","url":"https://stock-news.laohu8.com/highlight/detail?id=2635422459","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635422459?lang=zh_cn&edition=full","pubTime":"2026-05-13 08:12","pubTimestamp":1778631155,"startTime":"0","endTime":"0","summary":"恰逢此次机构调研窗口期,医渡科技官宣中标中肿重磅项目,其中智慧临床及结算服务升级建设项目金额达908万元。这是所有医疗AI面临的终极拷问。中肿在调研中提到,其AI相关投入占比持续提升,这极具代表性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158","BK1518","150261","BK1617","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634571420","title":"医渡科技(02158)再获中肿908万元AI订单 顶级医院深度复购印证营收爆发力","url":"https://stock-news.laohu8.com/highlight/detail?id=2634571420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634571420?lang=zh_cn&edition=full","pubTime":"2026-05-11 09:03","pubTimestamp":1778461399,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,5月11日,医渡科技发布自愿性公告,其联属公司医渡云(北京)技术有限公司近期中标中山大学附属肿瘤医院智慧临床及结算服务升级建设项目,中标金额约908.2万元。自2015年起,中肿与医渡科技便围绕肿瘤专科大数据平台展开深度合作。医渡科技正以标杆客户的持续复购为基本盘,加速验证AI商业化闭环。随着中肿等顶级医院深层AI建设的扩围,医渡科技有望率先步入业绩与估值双升周期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","AIPO","ARTY","02158","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634442793","title":"医渡科技(02158)多点利好共振:机构调研认可、深圳惠民保主运营、项目中标频传","url":"https://stock-news.laohu8.com/highlight/detail?id=2634442793","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634442793?lang=zh_cn&edition=full","pubTime":"2026-05-11 08:27","pubTimestamp":1778459242,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,近日,博裕投资、花旗、广发证券及多家头部私募机构赴中山大学肿瘤防治中心专项调研,实地考察医渡科技与中肿在医疗大数据、肿瘤AI全场景的深度落地成果。消息面上,医渡科技近期业务版图多点开花。2026年度“深圳惠民保”正式上线,医渡科技连续第四年担任主运营平台,再度印证公司的核心运营实力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439965.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1518","BK1617","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634087422","title":"医渡科技(02158)中标中国银行股份有限公司广东省分行中山大学附属肿瘤医院智慧临床及结算服务升级建设项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2634087422","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634087422?lang=zh_cn&edition=full","pubTime":"2026-05-11 08:11","pubTimestamp":1778458279,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医渡科技 发布公告,近期,公司的联属公司医渡云(北京)技术有限公司中标中山大学附属肿瘤医院的中国银行股份有限公司广东省分行中山大学附属肿瘤医院智慧临床及结算服务升级建设项目,项目总金额约为人民币908.2万元。医渡科技是驱动中国医疗体系智能化升级的核心力量,公司以智慧决策深度赋能“医、药、险、患”全产业链,致力于使精准医疗惠及每一个人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","LU1048588211.SGD","LU2097828805.USD","SG9999001093.SGD","BK1521","03143","SG9999006597.SGD","LU1282651121.HKD","LU1282651048.USD","BK0012","LU2097828714.EUR","IE00B19Z5X02.USD","HK0000286598.CNH","BK0188","BK1189","LU0293314216.USD","LU2097828557.USD","LU1497733557.USD","BK0015","BK0028","BK1560","LU1497734951.SGD","IE00BQJZWZ67.USD","LU0307460666.USD","LU2097828631.EUR","LU1497733631.SGD","LU1515016050.SGD","BK1231","BK0278","601988","BK1617","03988","LU0651947912.USD","LU0348805143.USD","LU0588546209.SGD","LU1522347837.USD","IE00BWDBJ730.SGD","LU0651946864.USD","02158","LU0072462343.USD","LU1051769294.HKD","LU1634259557.SGD","LU2097828474.EUR","LU1634259391.SGD","BK0183","LU1224444064.USD","LU1051768304.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633655488","title":"以AI破解惠民保“死亡螺旋” 医渡科技(02158)开启价值兑现新周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2633655488","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633655488?lang=zh_cn&edition=full","pubTime":"2026-05-08 11:21","pubTimestamp":1778210473,"startTime":"0","endTime":"0","summary":"年度保费仅88元、最高保额超过400万元的“深圳惠民保”再次开启参保通道。智通财经APP获悉,4月20日,医渡科技发布正面盈利预告,预计2026财年实现净利润5500万至7000万元人民币。更早之前,医渡科技已承建博鳌乐城真实世界数据研究平台,支撑22款国际创新药械获批上市。弗若斯特沙利文的预测显示,中国AI医疗市场规模将从2023年的88亿元飙升至2033年的3157亿元,年复合增长率高达43.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158","ARTY","BK1518","BK1617","AIPO","AGIX","CHAT","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176956143","title":"医渡科技更新2026年4月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1176956143","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176956143?lang=zh_cn&edition=full","pubTime":"2026-05-07 18:07","pubTimestamp":1778148461,"startTime":"0","endTime":"0","summary":"医渡科技有限公司于2026年5月7日发布截至2026年4月30日的股份变动月报表。公告显示,公司法定股本维持不变,已发行普通股数量略有增加。公司公告显示,报告期内公司法定股本维持在2,500,000,000股,面值为每股0.00002美元,总计50,000美元,较上月底无增减变动。截至2026年4月30日,已发行股份由上月底的1,019,808,585股增加至1,019,912,140股,新增103,555股,库存股份数量维持在52,906,100股,总股份数因此增至1,072,818,240股。报告期内无购回或注销股份活动。公告由董事宫盈盈签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633195553","title":"2026年度“深圳惠民保”正式上线 医渡科技(02158)连续四年担任主运营","url":"https://stock-news.laohu8.com/highlight/detail?id=2633195553","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633195553?lang=zh_cn&edition=full","pubTime":"2026-05-07 12:14","pubTimestamp":1778127252,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,今天上午,2026年度“深圳惠民保”正式上线。作为“政府指导、商保承办”的普惠型商业健康保险,2026年度“深圳惠民保”将持续深化“一站式”理赔直接结算服务,目前已覆盖深圳市内定点医疗机构及广东省内联网结算平台医院共8000余家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1617","BK1518","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633978310","title":"医渡科技(02158)附属成功中标Dr Buddy的落地实施及为其提供支持及维护","url":"https://stock-news.laohu8.com/highlight/detail?id=2633978310","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633978310?lang=zh_cn&edition=full","pubTime":"2026-05-06 06:17","pubTimestamp":1778019467,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医渡科技 发布公告,本公司附属公司EVYD Research Private Limited,近期中标Singapore Health Services Pte Ltd有关Dr Buddy的落地实施及为其提供支持及维护,项目总金额约为227.8万新加坡元。医渡科技是驱动中国医疗体系智能化升级的核心力量,集团以智慧决策深度赋能“医、药、险、患”全产业链,致力于使精准医疗惠及每一个人。医渡科技,以自主创新的系统级智能,创造更具韧性、更富关怀、更普惠高效的医疗健康未来。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","02158","BK1617","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631339746","title":"告别溯源泥潭:医渡科技(02158)如何重构临床试验的“数据基因”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2631339746","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631339746?lang=zh_cn&edition=full","pubTime":"2026-04-30 18:50","pubTimestamp":1777546207,"startTime":"0","endTime":"0","summary":"ESDR的技术逻辑:深耕医疗数智基建,从源头重构数据体系相较于行业多数产品聚焦事后纠错、局部优化的改良思路,医渡科技ESDR的核心破局逻辑,是将数据治理从事后修补全面前置为源头设计。医渡科技披露的几组项目数据,提供了初步的量化参考。ESDR的智能质控则实现了全量数据实时监控、异常自动预警。而ESDR代表的思路是:让数据成为临床试验的“第一性原理”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","02158","BK1189","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631592106","title":"医渡科技(02158)用一场路演引爆CHIMA,医疗AI下半场怎么打?","url":"https://stock-news.laohu8.com/highlight/detail?id=2631592106","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631592106?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:35","pubTimestamp":1777458936,"startTime":"0","endTime":"0","summary":"现场的火爆程度,折射出医疗从业者与管理者们对\"能落地、敢使用”AI方案的迫切渴望。截至2025年9月30日,YiduCore已累计处理分析近70亿份经授权的医疗记录,服务全国超过10,000家医院,疾病知识图谱基本覆盖所有已知疾病。这条在2026 CHIMA大会上发布的“智能体开发及协同应用”路径,不仅是面向AI医院未来交出的一份系统、落地的答卷,更标志着医疗AI的生产与消费关系正在发生深刻转型。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","150261","BK1617","02158","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630583631","title":"医渡科技(02158)中标广医科大附一院临床试验SMO项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2630583631","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630583631?lang=zh_cn&edition=full","pubTime":"2026-04-28 22:07","pubTimestamp":1777385264,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,4月28日,医渡科技发布自愿性公告,其联属公司医渡云(北京)技术有限公司中标广州医科大学附属第一医院的PIONEER2临床试验SMO技术服务项目,总金额约410万元。早在2022年,医渡科技的另一家联属公司——天津开心生活科技有限公司便已中标广州呼吸健康研究院的PIONEER研究技术服务项目,合同金额为585.5万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"医渡科技(02158)中标广医科大附一院临床试验SMO项目","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1189","BK1518","BK1617","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629817179","title":"医渡科技(02158)旗下医渡智循接入DeepSeek-V4,双模型协同临床辅助体验再升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2629817179","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629817179?lang=zh_cn&edition=full","pubTime":"2026-04-24 18:10","pubTimestamp":1777025439,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,4月24日,就在DeepSeek正式发布并开源新一代旗舰模型DeepSeek-V4预览版同日,医渡科技宣布,临床循证智能体“医渡智循”完成DeepSeek-V4与医渡大模型双基座架构的医学场景适配。如今DeepSeek-V4拥有100万Token上下文窗口,约等于40万汉字,足以装下一份完整住院病历甚至整本临床指南。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629813237","title":"医渡科技(02158)3-4倍PE背后的AI医疗价值重估新叙事","url":"https://stock-news.laohu8.com/highlight/detail?id=2629813237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629813237?lang=zh_cn&edition=full","pubTime":"2026-04-24 15:39","pubTimestamp":1777016366,"startTime":"0","endTime":"0","summary":"截止4月24日15时,在AI医疗龙头医渡科技当日十大买入经纪商中,外资占了七强,其中前六强均被处交资所垄断,引中JP摩根和摩根士丹利净买入超过50万股。这只是外资在医渡科技于4月20日发布盈喜公告后的一个缩影。2026财年上半年,医渡科技净亏损为1576万元,这意味着仅下半年,公司就实现了7076万元至8576万元的惊人盈利。从“烧钱”到“造血”,医渡科技用一份盈喜答卷,宣告了AI医疗商业化元年的到来。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AIPO","AGIX","BK1189","159891","CHAT","BK1518","ARTY","BK1617","02158"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0036},{"period":"1month","weight":-0.131},{"period":"3month","weight":-0.0717},{"period":"6month","weight":0.1461},{"period":"1year","weight":-0.0279},{"period":"ytd","weight":0.061}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0306},{"period":"6month","weight":0.0153},{"period":"1year","weight":0.0876},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"医渡科技有限公司是一家主要从事提供基于大数据和人工智能(AI)技术的医疗解决方案的投资控股公司。该公司主要通过三个分部运营其业务。大数据平台和解决方案分部从事提供数据智能平台及数据分析驱动的解决方案。生命科学解决方案分部从事为药物和医疗器械的全生命周期管理提供支持,涵盖从临床开发到上市后的各个阶段。健康管理平台和解决方案分部从事提供AI赋能的健康管理解决方案。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.077386},{"month":2,"riseRate":0.666667,"avgChangeRate":0.095773},{"month":3,"riseRate":0,"avgChangeRate":-0.131056},{"month":4,"riseRate":0.5,"avgChangeRate":0.012812},{"month":5,"riseRate":0,"avgChangeRate":-0.067999},{"month":6,"riseRate":0.6,"avgChangeRate":0.067533},{"month":7,"riseRate":0.2,"avgChangeRate":-0.05605},{"month":8,"riseRate":0.2,"avgChangeRate":-0.107097},{"month":9,"riseRate":0.6,"avgChangeRate":-0.067899},{"month":10,"riseRate":0.2,"avgChangeRate":-0.069507},{"month":11,"riseRate":0.6,"avgChangeRate":0.153719},{"month":12,"riseRate":0.6,"avgChangeRate":0.017309}],"exchange":"SEHK","name":"医渡科技","nameEN":"YIDU TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医渡科技,02158,医渡科技股票,医渡科技股票老虎,医渡科技股票老虎国际,医渡科技行情,医渡科技股票行情,医渡科技股价,医渡科技股市,医渡科技股票价格,医渡科技股票交易,医渡科技股票购买,医渡科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}